Cover Image
市場調查報告書

眼科用影像設備:醫療設備的開發平台評估

Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 347933
出版日期 內容資訊 英文 111 Pages
訂單完成後即時交付
價格
Back to Top
眼科用影像設備:醫療設備的開發平台評估 Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年11月14日 內容資訊: 英文 111 Pages
簡介

本報告提供全球眼科影像設備市場上主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品特性比較分析 (臨床實驗的各進展階段) ,並彙整主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等)等資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 眼科用影像設備市場概要

第3章 眼科用影像設備市場:臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:估計各認證時期
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 眼科用影像設備的企業:各臨床實驗階段的開發中產品
  • 眼科用影像設備:各臨床實驗階段的開發中產品

第5章 眼科用影像設備市場:企業·產品概要

  • Aeon Imaging, LLC
    • 開發中產品及進行中的臨床實驗概要
  • Aeon Scientific AG
  • ArcScan, Inc.
  • Brien Holden Vision Institute
  • CW Optics, Inc.
  • Dalhousie University
  • Exploit Technologies Pte Ltd
  • Eye Marker Systems, Inc.
  • Eyenuk Inc.
  • EyeTechCare SA
  • Gemss Co.,Ltd.
  • Massachusetts Eye and Ear Infirmary
  • Next Dimension Ltd.
  • OcuSciences, Inc.
  • Ocutronics, LLC
  • Optos Plc
  • PCAsso Diagnostics LLC
  • Praevium Research Inc.
  • Predictek, Inc.
  • Rensselaer Polytechnic Institute
  • RetiVue, LLC
  • Tufts University
  • University College London
  • University of Arizona
  • University of California, Berkeley
  • University of Valencia
  • Vision Instruments Pty. Ltd.
  • VisionQuest Biomedical, LLC
  • Visual Pathways, Inc. (Inactive)

第6章 眼科用影像設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0253EPD

GlobalData's Medical Devices sector report, "Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2016" provides an overview of Ophthalmic Imaging Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Imaging Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Ophthalmic Imaging Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ophthalmic Imaging Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ophthalmic Imaging Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Ophthalmic Imaging Equipment Overview

3. Products under Development

  • 3.1. Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • 3.2. Ophthalmic Imaging Equipment - Pipeline Products by Segment
  • 3.3. Ophthalmic Imaging Equipment - Pipeline Products by Territory
  • 3.4. Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
  • 3.5. Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date
  • 3.6. Ophthalmic Imaging Equipment - Ongoing Clinical Trials

4. Ophthalmic Imaging Equipment - Pipeline Products under Development by Companies

  • 4.1. Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development
  • 4.2. Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development

5. Ophthalmic Imaging Equipment Companies and Product Overview

  • 5.1. Aeon Imaging, LLC Company Overview
    • 5.1.1. Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Aeon Scientific AG Company Overview
    • 5.2.1. Aeon Scientific AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. ArcScan, Inc. Company Overview
    • 5.3.1. ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Ben-Gurion University of the Negev Company Overview
    • 5.4.1. Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Brien Holden Vision Institute Company Overview
    • 5.5.1. Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. CW Optics, Inc. Company Overview
    • 5.6.1. CW Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Dalhousie University Company Overview
    • 5.7.1. Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Exploit Technologies Pte Ltd Company Overview
    • 5.8.1. Exploit Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Eye Marker Systems, Inc. Company Overview
    • 5.9.1. Eye Marker Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Eye Tech Care SA Company Overview
    • 5.10.1. Eye Tech Care SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Gemss Co.,Ltd. Company Overview
    • 5.11.1. Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. George Washington University Company Overview
    • 5.12.1. George Washington University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Massachusetts Eye and Ear Infirmary Company Overview
    • 5.13.1. Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Moorfields Eye Hospital NHS Foundation Trust Company Overview
    • 5.14.1. Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Next Dimension Ltd. Company Overview
    • 5.15.1. Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. OcuSciences, Inc. Company Overview
    • 5.16.1. OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Ocutronics, LLC Company Overview
    • 5.17.1. Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Ohio State University Company Overview
    • 5.18.1. Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Optos Plc Company Overview
    • 5.19.1. Optos Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. PCAsso Diagnostics LLC Company Overview
    • 5.20.1. PCAsso Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Praevium Research Inc. Company Overview
    • 5.21.1. Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Predictek, Inc. Company Overview
    • 5.22.1. Predictek, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Rensselaer Polytechnic Institute Company Overview
    • 5.23.1. Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. RetiVue, LLC Company Overview
    • 5.24.1. RetiVue, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Ti-TaMed (PTY) LTD. Company Overview
    • 5.25.1. Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Tufts University Company Overview
    • 5.26.1. Tufts University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Universite de Montreal Company Overview
    • 5.27.1. Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. University College London Company Overview
    • 5.28.1. University College London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. University of Arizona Company Overview
    • 5.29.1. University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. University of California, Los Angeles Company Overview
    • 5.30.1. University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. University of Colorado Company Overview
    • 5.31.1. University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. University of South Florida Company Overview
    • 5.32.1. University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. University of Valencia Company Overview
    • 5.33.1. University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Vision Instruments Pty. Ltd. Company Overview
    • 5.34.1. Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. VisionQuest Biomedical, LLC Company Overview
    • 5.35.1. VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Visual Pathways, Inc. (Inactive) Company Overview
    • 5.36.1. Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

6. Ophthalmic Imaging Equipment- Recent Developments

  • 6.1. Nov 07, 2016: Molecular Partners Announces Management Change
  • 6.2. Nov 02, 2016: NOVADAQ Reports Third Quarter 2016 Financial Results
  • 6.3. Oct 27, 2016: Molecular Partners: Quarterly Management Statement For The Period Ending September 30, 2016
  • 6.4. Oct 27, 2016: ContextVision Presents Q3 2016 Financial Report
  • 6.5. Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer
  • 6.6. Oct 11, 2016: DigiSight Technologies Showcases State-of-the-Art Paxos Scope Mobile Imaging Solution At AAO 2016
  • 6.7. Sep 28, 2016: Hill-Rom Adding More Than 100 Jobs In Central New York
  • 6.8. Sep 12, 2016: Canon U.S.A. to Display Eyecare Devices and Solutions at Vision Expo West
  • 6.9. Sep 09, 2016: KKR Invests USD66 Million in AcuFocus
  • 6.10. Sep 01, 2016: Molecular Partners reports unaudited half-year results for 2016: A period of continued progress for Molecular Partners
  • 6.11. Aug 18, 2016: ContextVision presents Q2 2016 financial report
  • 6.12. Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery
  • 6.13. Aug 08, 2016: TearScience Names Edward J. Holland, MD to Board of Directors
  • 6.14. Aug 02, 2016: MCW Researchers Lead Imaging Study of Patients with Genetic Color Vision Disorder in Advance of AGTC Gene Therapy Clinical Trials
  • 6.15. Jul 27, 2016: NOVADAQ Reports Second Quarter 2016 Financial Results
  • 6.16. Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization
  • 6.17. Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board
  • 6.18. Jul 13, 2016: CoxHealth brings diabetic digital retinal imaging to its patients
  • 6.19. Jul 06, 2016: Natus Medical Acquires RetCam Ophthalmic Imaging Systems from Clarity Medical Systems for USD10.6 Million
  • 6.20. Jul 06, 2016: NOVADAQ Announces Appointment of Rick Mangat as President and CEO
  • 6.21. Jun 24, 2016: AcuFocus Raises USD1.9 Million in Venture Financing
  • 6.22. May 16, 2016: Escalon Medical Reports Third Quarter Fiscal 2016 Results
  • 6.23. May 11, 2016: Carl Zeiss Meditec Records Revenue Growth of 8.6 Percent
  • 6.24. May 11, 2016: Nephros Reports First Quarter 2016 Financial Results
  • 6.25. May 05, 2016: TearScience Introduces LipiScan For Rapid High Definition Meibomian Imaging
  • 6.26. May 02, 2016: Large UK National Health Services (NHS) Study Finds EyeArt Device To Be the Most Sensitive Automated Retinal Image Analysis Technology for Diabetic Retinopathy Screening
  • 6.27. Apr 29, 2016: Bausch + Lomb Highlights Scientific and Clinical Research during the Association for Research in Vision and Ophthalmology Annual Meeting in Seattle, WA
  • 6.28. Apr 28, 2016: Quarterly Management Statement For The Period Ending March 31, 2016
  • 6.29. Apr 14, 2016: ArcScan receives CE Mark Approval for Its Insight 100 device enabling commercialization across Europe
  • 6.30. Apr 13, 2016: Molecular Partners Raises USD31.7 Million in Private Placement of Shares
  • 6.31. Apr 12, 2016: iSTAR Medical Raises USD11.4 Million in Series B Financing
  • 6.32. Mar 22, 2016: Breakthrough Handheld Technology from Welch Allyn Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings
  • 6.33. Mar 17, 2016: AcuFocus Raises USD4 Million in Financing
  • 6.34. Feb 29, 2016: Canon U.S.A. Showcases Solutions and Services that can Help Healthcare Providers Achieve a More Complete EHR Strategy at HIMSS 2016
  • 6.35. Feb 16, 2016: Escalon Medical Reports Second Quarter Fiscal 2016 Results
  • 6.36. Feb 04, 2016: Molecular Partners reports unaudited financial results for 2015
  • 6.37. Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund
  • 6.38. Jan 24, 2016: Fallas Family Vision of McDonough, Georgia, Adds OptoMap Retinal System for an Ultra-Wide View of the Retina During Eye Exams
  • 6.39. Jan 15, 2016: Remidio Innovative Solutions Raises Funds in Series B Financing
  • 6.40. Jan 11, 2016: Bausch + Lomb Announces 2016 Elite Vendor Relationship with Vision Source
  • 6.41. Dec 10, 2015: Molecular Partners received a European Small and Mid-Cap Award
  • 6.42. Dec 03, 2015: ArcScan Finalizes US Food and Drug Administration Submission for Its Insight 100 Ophthalmic Medical Device

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • Table 2: Ophthalmic Imaging Equipment - Pipeline Products by Segment
  • Table 3: Ophthalmic Imaging Equipment - Pipeline Products by Territory
  • Table 4: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
  • Table 5: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date
  • Table 6: Ophthalmic Imaging Equipment - Ongoing Clinical Trials
  • Table 7: Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development
  • Table 8: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • Table 9: Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: DLP - Cam - Product Status
  • Table 11: DLP - Cam - Product Description
  • Table 12: Aeon Scientific AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: OctoMag System - Product Status
  • Table 14: OctoMag System - Product Description
  • Table 15: ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Artemis 3 - Product Status
  • Table 17: Artemis 3 - Product Description
  • Table 18: ArcScan, Inc. - Ongoing Clinical Trials Overview
  • Table 19: Artemis 3 - Early Detection of Keratoconus
  • Table 20: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Diagnostic Tool - Retinal Disorders - Product Status
  • Table 22: Diagnostic Tool - Retinal Disorders - Product Description
  • Table 23: Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Advanced Retinal Imaging System - Product Status
  • Table 25: Advanced Retinal Imaging System - Product Description
  • Table 26: CW Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: RetinalImager - Product Status
  • Table 28: RetinalImager - Product Description
  • Table 29: Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Eye Imaging Device - Product Status
  • Table 31: Eye Imaging Device - Product Description
  • Table 32: Exploit Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Ocular Surface Disease Diagnostic System - Product Status
  • Table 34: Ocular Surface Disease Diagnostic System - Product Description
  • Table 35: Eye Marker Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: RTD 1000 - Product Status
  • Table 37: RTD 1000 - Product Description
  • Table 38: Eye Tech Care SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: EyeOP1 - Product Status
  • Table 40: EyeOP1 - Product Description
  • Table 41: Eye Tech Care SA - Ongoing Clinical Trials Overview
  • Table 42: EyeOP1 - EYEOP1, A Minimally-invasive, Single Use Ultrasound System Intended To Treat Refractory Glaucoma
  • Table 43: EyeOP1 - EYEOP1, A Minimally-invasive, Single Use Ultrasound System Intended To Treat Refractory Glaucoma
  • Table 44: EyeOP1 - Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients
  • Table 45: Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Motorized C-arm System - Product Status
  • Table 47: Motorized C-arm System - Product Description
  • Table 48: George Washington University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: iEye - Product Status
  • Table 50: iEye - Product Description
  • Table 51: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: Portable Mydriatic Cameras - Product Status
  • Table 53: Portable Mydriatic Cameras - Product Description
  • Table 54: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Binocular Optical Coherence Tomography - Product Status
  • Table 56: Binocular Optical Coherence Tomography - Product Description
  • Table 57: Moorfields Eye Hospital NHS Foundation Trust - Ongoing Clinical Trials Overview
  • Table 58: Binocular Optical Coherence Tomography - A Prospective Single-Site Non-Interventional Study to Evaluate Human Factors and Usability of Automated, Comprehensive Ocular Examination in Elderly and Visually Impaired Populations Using a Prototype Binocular Optical Coherence Tomography System
  • Table 59: Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Retinal Spectral Imaging System - Product Status
  • Table 61: Retinal Spectral Imaging System - Product Description
  • Table 62: OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: OcuMet Beacon - Product Status
  • Table 64: OcuMet Beacon - Product Description
  • Table 65: Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: Ocutronics OC-100 Retinal Camera - Product Status
  • Table 67: Ocutronics OC-100 Retinal Camera - Product Description
  • Table 68: Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Interferometric Imaging System - Product Status
  • Table 70: Interferometric Imaging System - Product Description
  • Table 71: Optos Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: 200TX Replacement Device - Product Status
  • Table 73: 200TX Replacement Device - Product Description
  • Table 74: CHARLOTTE - Product Status
  • Table 75: CHARLOTTE - Product Description
  • Table 76: INDIANAPOLIS - Product Status
  • Table 77: INDIANAPOLIS - Product Description
  • Table 78: Optos Plc - Ongoing Clinical Trials Overview
  • Table 79: 200TX Replacement Device - A Randomized Trial of Non-mydriatic Ultra-widefield Retinal Imaging to Screen for Diabetic Eye Disease: CLEAR SIGHT
  • Table 80: PCAsso Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: PolyChromatic Angiography Device - Product Status
  • Table 82: PolyChromatic Angiography Device - Product Description
  • Table 83: Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: VCSEL Based OCT System - Product Status
  • Table 85: VCSEL Based OCT System - Product Description
  • Table 86: Predictek, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: IRis - Product Status
  • Table 88: IRis - Product Description
  • Table 89: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Video Scheimpflug Camera - Product Status
  • Table 91: Video Scheimpflug Camera - Product Description
  • Table 92: RetiVue, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: CAVCAM - Product Status
  • Table 94: CAVCAM - Product Description
  • Table 95: Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 96: Optical Device - Product Status
  • Table 97: Optical Device - Product Description
  • Table 98: Tufts University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 99: Digital Single Lens Reflex Adaptor - Product Status
  • Table 100: Digital Single Lens Reflex Adaptor - Product Description
  • Table 101: Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: Diagnostic Software - Ocular Rigidity - Product Status
  • Table 103: Diagnostic Software - Ocular Rigidity - Product Description
  • Table 104: University College London Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: Ocular Imaging System - Product Status
  • Table 106: Ocular Imaging System - Product Description
  • Table 107: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
  • Table 108: Retinal Illumination System - Product Status
  • Table 109: Retinal Illumination System - Product Description
  • Table 110: University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • Table 111: Corneal Hydration Sensing System - Product Status
  • Table 112: Corneal Hydration Sensing System - Product Description
  • Table 113: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
  • Table 114: Multi-Photon Optics Device - Product Status
  • Table 115: Multi-Photon Optics Device - Product Description
  • Table 116: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Table 117: Adaptive Optics Ophthalmic Imager - Product Status
  • Table 118: Adaptive Optics Ophthalmic Imager - Product Description
  • Table 119: University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
  • Table 120: 3D Imaging Retinal Camera - Product Status
  • Table 121: 3D Imaging Retinal Camera - Product Description
  • Table 122: Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 123: ViNM1 Retinal Camera - Product Status
  • Table 124: ViNM1 Retinal Camera - Product Description
  • Table 125: VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 126: DR-RACS - Product Status
  • Table 127: DR-RACS - Product Description
  • Table 128: Functional Scanning Laser Ophthalmoscope - Product Status
  • Table 129: Functional Scanning Laser Ophthalmoscope - Product Description
  • Table 130: VisionQuest Biomedical, LLC - Ongoing Clinical Trials Overview
  • Table 131: DR-RACS - Phase 0 Observational Study of a Computer-based Screening Algorithm for Detection of Diabetic Retinopathy
  • Table 132: Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 133: Aris HySpect - Product Status
  • Table 134: Aris HySpect - Product Description
  • Table 135: Aris Pixie - Product Status
  • Table 136: Aris Pixie - Product Description
  • Table 137: ArisWareEP-3D - Product Status
  • Table 138: ArisWareEP-3D - Product Description
  • Table 139: Glossary

List of Figures

  • Figure 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • Figure 2: Ophthalmic Imaging Equipment - Pipeline Products by Segment
  • Figure 3: Ophthalmic Imaging Equipment - Pipeline Products by Territory
  • Figure 4: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
  • Figure 5: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date
  • Figure 6: Ophthalmic Imaging Equipment - Ongoing Clinical Trials
Back to Top